Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.

European Glaucoma Prevention Study (EGPS) Group, Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I.

Ophthalmology. 2007 Jan;114(1):3-9. Epub 2006 Oct 27.

PMID:
17070596
2.

The European glaucoma prevention study design and baseline description of the participants.

Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I; European Glaucoma Prevention Study Group.

Ophthalmology. 2002 Sep;109(9):1612-21.

PMID:
12208707
3.

Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.

Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I; EGPS Group.

Am J Ophthalmol. 2007 Aug;144(2):266-275. Epub 2007 Jun 4.

PMID:
17543874
4.

Results of the European Glaucoma Prevention Study.

Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I; European Glaucoma Prevention Study (EGPS) Group.

Ophthalmology. 2005 Mar;112(3):366-75.

PMID:
15745761
5.

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.

Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL, Parrish RK, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group.

Ophthalmology. 2006 Sep;113(9):1603-12.

PMID:
16949445
6.

The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.

Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW; Low-Pressure Glaucoma Study Group.

Ophthalmology. 2005 Mar;112(3):376-85.

PMID:
15745762
7.

Predictive value of heidelberg retina tomograph parameters for the development of glaucoma in the European glaucoma prevention study.

Miglior S, Zeyen T, Hoffmann EM, Torri V, Rulli E, Floriani I, Poli D, Aliyeva S, Cunha-Vaz J, Pfeiffer N.

Am J Ophthalmol. 2015 Feb;159(2):265-76.e1. doi: 10.1016/j.ajo.2014.10.028. Epub 2014 Nov 1.

PMID:
25448996
8.

Central corneal thickness in the European Glaucoma Prevention Study.

European Glaucoma Prevention Study Group, Pfeiffer N, Torri V, Miglior S, Zeyen T, Adamsons I, Cunha-Vaz J.

Ophthalmology. 2007 Mar;114(3):454-9. Epub 2006 Nov 27.

PMID:
17126403
9.

Predictors of long-term progression in the early manifest glaucoma trial.

Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group.

Ophthalmology. 2007 Nov;114(11):1965-72. Epub 2007 Jul 12.

PMID:
17628686
10.

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group, Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA.

Ophthalmology. 2007 Jan;114(1):10-9. Epub 2006 Nov 7.

11.

Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.

Bengtsson B, Leske MC, Hyman L, Heijl A; Early Manifest Glaucoma Trial Group.

Ophthalmology. 2007 Feb;114(2):205-9. Epub 2006 Nov 13.

PMID:
17097736
12.

Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.

Parisi V, Miglior S, Manni G, Centofanti M, Bucci MG.

Ophthalmology. 2006 Feb;113(2):216-28. Epub 2006 Jan 10.

PMID:
16406535
13.

The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.

Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group.

Ophthalmology. 2008 Nov;115(11):2030-6. doi: 10.1016/j.ophtha.2008.06.036. Epub 2008 Sep 18.

14.

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA.

Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30.

PMID:
12049575
15.

The Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.

Hoffmann EM, Miglior S, Zeyen T, Torri V, Rulli E, Aliyeva S, Floriani I, Cunha-Vaz J, Pfeiffer N.

Acta Ophthalmol. 2013 Dec;91(8):e612-9. doi: 10.1111/aos.12180. Epub 2013 May 25.

16.

Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.

Coleman AL, Gordon MO, Beiser JA, Kass MA; Ocular Hypertension Treatment Study.

Am J Ophthalmol. 2004 Oct;138(4):684-5.

PMID:
15488816
18.

Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.

Medeiros FA, Weinreb RN, Zangwill LM, Alencar LM, Sample PA, Vasile C, Bowd C.

Ophthalmology. 2008 Jun;115(6):934-40. Epub 2007 Oct 15.

19.

Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.

Leung DY, Tham CC, Li FC, Kwong YY, Chi SC, Lam DS.

Ophthalmology. 2009 Jul;116(7):1250-6. doi: 10.1016/j.ophtha.2009.02.003. Epub 2009 May 30.

PMID:
19481813
20.

Incident open-angle glaucoma and intraocular pressure.

Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC; Barbados Eye Studies Group.

Ophthalmology. 2007 Oct;114(10):1810-5. Epub 2007 Jun 20.

PMID:
17583352
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk